Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found ...

Congenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...

The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also ...

Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward ...

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but ...

It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...